Introduction
Regarding dry eye syndromes such as keratoconjunctivitis sicca (KCS), more women than men are affected, especially during pregnancy (predominance of gestagens) and the early phase of menopause. [1] [2] [3] Meibomian gland dysfunction and evaporative dry eye often occur during menopause and aging. 1 In climacteric women, presumably the lower Oestrogen level is responsible for the higher incidence of KCS. 2, 3 Additionally, an attenuation in androgen synthesis during menopause contributes to KCS by leading to meibomian gland dysfunction. 1 Since Oestrogen-dependent cycle-associated histological changes of the conjunctiva have been observed, systemic hormone replacement therapy (HRT) was suggested to be indicated in patients with KCS. 2 This was supported by investigations in climacteric women with a lower incidence of dry eye complaints under systemic HRT. 3 In contradiction, data from the Woman Health Study, a large cohort study with more than 25 000 postmenopausal women, suggested an increased risk of KCS in women who used systemic HRT, particularly Oestrogen alone. 4 Therefore, the authors of the study recommended not to prescribe HRT for eye symptoms in postmenopausal women. 4 However, the value of this statement is limited due to the fact that the indications for systemic HRT were not analysed exactly regarding onset and duration of dry eye symptoms. The one and only randomized clinical trial published so far compared patients with and without Oestrogen-containing artificial tears in KCS combined with systemic HRT. 5 In that study, a statistically significant improvement by topical HRT was demonstrated concerning subjective complaints and objective parameters. 5 Oestrogen seemed to influence the production of the aqueous component of the tear film. 5 The effect of Oestrogen therapy on lacrimal gland, conjunctiva, and/or meibomian glands may be transmitted by Oestrogen receptors (ERs) or in a receptor-independent way. ERs are ligand-dependent transcriptional activators regulating gene expression via complex mechanisms. 6 Two ER isoforms a and b have been isolated, mapping on different chromosomes (ERa on chromosome 6 and ERb on chromosome 14). 6 Based on mRNA analyses, ERa is predominantly expressed in specific female tissues, whereas ERb is expressed in many tissues, for example, the central nervous system. 6 The affinity for Oestradiol is comparable for both receptor subtypes, but ERb seems to be predominant, when both ERb and ERa are present. 6 Based on different structure and distribution, these ER isoforms are suggested to have different biological activity. 6 However, function of ERb is not yet understood. 6 Recent research revealed ERa mRNA as well as androgen and progesterone receptor mRNA in a series of ocular tissue samples (n ¼ 20) derived from the lacrimal gland, the eye lid and the conjunctiva by RT-PCR. 7 Regarding ocular tissues, ERb mRNA was detected only in the human cornea and retina to date. 8, 9 With immunohistochemical techniques, ERa could be detected in meibomian glands both in male and female subjects. 10 Depending on age, ERa expression was also proven in the female neurosensory retina and the retinal pigment epithelium. 11 Owing to insufficient commercial availability, unsatisfactory characterization and limited applications of ERb antibodies, 6 only one immunohistochemical study exists regarding distribution of ERb in ocular tissues. 9 To date, ERs have not been detected in tear-producing tissues using monoclonal antibodies. 12, 13 Based on pathophysiological and therapeutical considerations, this study was conducted to analyse ERa and ERb expression in the tear-producing tissues.
Materials and methods
After obtaining approval by the local ethics committee and written informed consent biopsies of bulbar conjunctiva (3 Â 3 mm, n ¼ 20) and tarsal plates (n ¼ 14) were obtained from volunteers without symptoms of conjunctival, palpebral, or lacrimal gland disease during cataract surgery (20 patients) and lower lid excisions (12 patients), respectively. Lacrimal gland tissue (n ¼ 20) was taken post mortem from 13 ophthalmologically normal cornea donors on the occasion of cornea removal. All samples were immediately frozen in liquid nitrogen and stored at À801C until preparation. The study was performed according to the Declaration of Helsinki.
The samples were collected between September 1999 and July 2000. The mean volunteer age was 71.0 years (38-90 years), the mean cornea donor age was 76.2 (63-89 years). In total, 32 volunteers and donors were female, 13 male (Tables 1 and 2 ). At the time of tissue sampling, female subjects were elder than males (mean age 75.0 vs 68.0 years).
In all, 10 samples of each conjunctival and lacrimal gland tissue and 8 samples of tarsal tissue were analysed by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for ERa and ERb.
14 After RNA extraction and cDNA synthesis, the expression of the steroid receptors ERa and ERb was determined in comparison to the reference gene GADPH as an internal standard. The fluorescence labelled PCR products were analysed on an automated fluorescent DNA sequencer (A.L.F., Pharmacia).
Another 10 samples of each conjunctival and lacrimal gland tissue and six samples of tarsal tissue were prepared immunohistochemically for localization of ERa. The Vectastain ABC Elite avidin/biotin/peroxidase kit (Vector Laboratories, Burlingame, CA, USA) in combination with the monoclonal antibody Figure 1 ).
Neither the expression of ERa mRNA or of ERb mRNA nor positive immunohistochemical staining for ERa was associated with age or gender (all differences not statistically significant, Table 3 ).
Discussion
In this study, messenger RNA ERa was identified via RT-PCR in nearly all samples of conjunctival, tarsal, and lacrimal gland tissue with variable expression. In contrast, ERb mRNA was detected nearly exclusively in lacrimal gland tissue. The mainly negative results of ERb in conjunctiva and tarsal plates may be explained by tissue-specific receptor expression. Since our data showed no statistical significant association of ERa or ERb expression neither with age nor with gender, a presumed loss of expression due to the higher age of most of the volunteers do not seem to play an important role. This is in contrast to the findings of Ogueta et al, 11 who were the only one, who described an age-and gender-dependent mRNA expression of ERa in a human ocular tissue, here in human neuroretina.
Slight immunohistochemical staining of ERa was demonstrated in four bulbar conjunctival samples and two lacrimal gland samples only (Figure 1 ). All other samples were negative. In breast cancer, expression of ER is evaluated in a score according to the ratio of stained vs unstained cells and the intensity of staining. 15 Since scores for ocular tissues do not exist, such a procedure was not feasible in this study. The negative immunohistochemistry results in this study, which are in contrast to the proof of ERa on the transcriptional level, may have been affected by fixation, embedding, rehydration, and the specificity of the antibody itself. 6 On the other hand, the absence of immunoreactivity, may also be explained by very low levels of ERa protein below the sensitivity of detection of the assay. 11 Furthermore, the method may be unsuitable for ER localization in ocular tissues.
For clinical use, first encouraging results with topical Oestrogen in postmenopausal women have been published. 5 Oestrogens lead to maturation of the conjunctival surface characterized by preponderance of superficial cells and influence the production of the aqueous components of the tear film. 2 Hypothetically, presuming a lacrimal gland specific distribution of ERb among the tear producing tissues and a predominance of ERb, when both receptor isoforms are present, this might explain the positive influence of topical oestradiol on the aqueous component of the tear film. 5, 6 Nevertheless, Oestrogens enhance proinflammatory cytokines, such as IL-1, TNF, and/or IL-6 and, therefore, maintain an inflammatory component in KCS. 16 Moreover, it was demonstrated recently that 17b-Oestradiol induced a marked increase of mRNA levels of IL-1b, IL-6, IL-8, and GM-CSF in human corneal epithelial cells, contributing to the pathogenesis of ocular surface inflammation in KCS. 17 Androgens, on the other hand, decrease inflammatory processes and regulate meibomian gland function with subsequent improved lipid layer of the tear film. 16 Androgen deficiency, which occurs in postmenopausal women besides Oestrogen deficiency, leads to an altered lipid profile with reduced tear film break-up time and subsequent tear film instability. 1 One case report was published describing successful treatment of KCS in a 54-year-old male resulting in a restored lipid phase of the tear film. 16, 18 In summary, according to the results of RT-PCR a receptor-mediated effect of Oestrogens via ERa is likely in all three tissues. In lacrimal gland tissue, ERb may play an additive role. Clinically, there may be evidence that KCS especially in elderly women is more probably caused by androgen deficiency rather than by the lack of Oestrogen. 19 Therefore, topical Oestrogen administration might be more effective in combination with topical androgen in KCS. 
